Clinical trial
WEUKBRE6076: Belimumab (BENLYSTA) Pregnancy Registry Protocol
NCT01532310 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- WEUKBRE6076: Belimumab (BENLYSTA) Pregnancy Registry Protocol
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 16, 2012
- Completion date
- November 11, 2022
- Enrollment
- 77 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
systemic lupus erythematosus